The effect of Clostridium difficile infection on cardiac surgery outcomes
- PMID: 25402213
- DOI: 10.1089/sur.2013.097
The effect of Clostridium difficile infection on cardiac surgery outcomes
Abstract
Background: Clostridium difficile (CD) is a common cause of healthcare-associated infectious colitis that complicates about 1% of all hospital stays in the U.S. The impact of CD on outcomes after coronary artery bypass grafting (CABG) and valvular surgery (VS) is not well known.
Methods: The Nationwide Inpatient Sample (2002-2009) was queried to identify CABG and VS patients utilizing International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. Rates of CD, post-operative endocarditis and mediastinitis, hospital mortality rate, and resource utilization were evaluated.
Results: We identified 421,294 and 90,923 patients of age 40 yrs and older who underwent CABG and VS, respectively. The CD infection was more likely to develop in patients undergoing VS than in those having CABG (odds ratio [OR] 1.8; 95% confidence interval [CI] 1.64-1.92) and was more likely after urgent or emergency admission than after elective admission (OR 1.8; 95% CI 1.68-1.94). There was a greater likelihood of mediastinitis in patients with CD after CABG than in non-complicated cases without CD, both by univariable (OR 6.0; 95% CI 3.07-11.62) and multivariable analysis with adjustment for patient age, gender, race, type of admission, and co-morbidities (OR 3.1; 95% CI 1.49-6.51). The infection thus was most likely a result of the antibiotics used to treat mediastinitis, as the patients treated for mediastinitis were most likely to develop CD. There was a significant association in patients with CD and endocarditis who underwent VS but not in patients who did not have CD. The CD infection in these patients thus was most likely a result of the antibiotics used to treat endocarditis. Endocarditis and CD developed 3.2 times (95% CI 2.65-3.97) as often as in patients without CD, a finding that was confirmed by multivariable analysis (OR 2.2; 95% CI 1.70-2.84). At the same time, in patients having VS, there was no significant association of CD and mediastinitis. Clostridium difficile infection affected the hospital mortality rate significantly after both CABG (OR 2.0; 95% CI 1.65-2.35) and VS (OR 1.9; 95% CI 1.51-2.39). Development of CD increased median hospital length of stay and cost dramatically after both CABG (from 7 d to 19 d and from $33,105 to $65,535, respectively; p<0.0001 for both) and VS (from 8 d to 24 d and from $41,876 to $95,699, respectively; p<0.0001 for both).
Conclusions: The development of CD worsened significantly the outcomes of adult patients undergoing cardiac surgery. There was a greater risk of CD in patients with either mediastinitis or endocarditis. The infection was associated with a higher hospital mortality rate, longer hospital stays, and greater cost after both CABG and VS.
Similar articles
-
The burden of Clostridium difficile in surgical patients in the United States.Surg Infect (Larchmt). 2007 Dec;8(6):557-66. doi: 10.1089/sur.2006.062. Surg Infect (Larchmt). 2007. PMID: 18171114
-
Clostridium difficile colitis in patients undergoing lumbar spine surgery.Spine (Phila Pa 1976). 2014 Sep 1;39(19):E1167-73. doi: 10.1097/BRS.0000000000000487. Spine (Phila Pa 1976). 2014. PMID: 24979408
-
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients.Am J Gastroenterol. 2008 Jun;103(6):1443-50. doi: 10.1111/j.1572-0241.2007.01780.x. Epub 2008 May 29. Am J Gastroenterol. 2008. PMID: 18513271
-
Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.J Hosp Infect. 2014 Sep;88(1):12-21. doi: 10.1016/j.jhin.2014.04.011. Epub 2014 May 17. J Hosp Infect. 2014. PMID: 24996516 Review.
-
Timing and type of surgical treatment of Clostridium difficile-associated disease: a practice management guideline from the Eastern Association for the Surgery of Trauma.J Trauma Acute Care Surg. 2014 Jun;76(6):1484-93. doi: 10.1097/TA.0000000000000232. J Trauma Acute Care Surg. 2014. PMID: 24854320 Review.
Cited by
-
Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.Gut Microbes. 2022 Jan-Dec;14(1):2117504. doi: 10.1080/19490976.2022.2117504. Gut Microbes. 2022. PMID: 36045589 Free PMC article.
-
Prognostic role of perioperative acid-base disturbances on the risk of Clostridioides difficile infection in patients undergoing cardiac surgery.PLoS One. 2021 Mar 17;16(3):e0248512. doi: 10.1371/journal.pone.0248512. eCollection 2021. PLoS One. 2021. PMID: 33730090 Free PMC article.
-
Evaluation of risk factors for a fulminant Clostridium difficile infection after cardiac surgery: a single-center, retrospective cohort study.BMC Anesthesiol. 2018 Sep 27;18(1):133. doi: 10.1186/s12871-018-0597-2. BMC Anesthesiol. 2018. PMID: 30257648 Free PMC article.
-
Discontinuation of Postoperative Prophylactic Antibiotics After Noninstrumented Spinal Surgery: Results of a Quality Improvement Project.Neurohospitalist. 2018 Jul;8(3):129-134. doi: 10.1177/1941874417748542. Epub 2018 Jan 21. Neurohospitalist. 2018. PMID: 29977443 Free PMC article.
-
A multi-institutional cohort study confirming the risks of Clostridium difficile infection associated with prolonged antibiotic prophylaxis.J Thorac Cardiovasc Surg. 2018 Feb;155(2):670-678.e1. doi: 10.1016/j.jtcvs.2017.09.089. Epub 2017 Sep 28. J Thorac Cardiovasc Surg. 2018. PMID: 29102205 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
